ResMed, Inc. (RMD)
218.89
-2.26
(-1.02%)
USD |
NYSE |
Oct 02, 16:00
219.04
+0.14
(+0.07%)
After-Hours: 20:00
ResMed Market Cap : 31.57B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 31.57B |
| October 01, 2026 | 31.90B |
| September 30, 2026 | 31.89B |
| September 29, 2026 | 32.14B |
| September 28, 2026 | 32.04B |
| September 25, 2026 | 32.02B |
| September 24, 2026 | 32.01B |
| September 23, 2026 | 32.06B |
| September 22, 2026 | 32.02B |
| September 21, 2026 | 32.25B |
| September 18, 2026 | 32.45B |
| September 17, 2026 | 32.95B |
| September 16, 2026 | 32.92B |
| September 15, 2026 | 33.09B |
| September 14, 2026 | 32.16B |
| September 11, 2026 | 31.48B |
| September 10, 2026 | 31.67B |
| September 09, 2026 | 31.73B |
| September 08, 2026 | 31.88B |
| September 04, 2026 | 32.94B |
| September 03, 2026 | 33.06B |
| September 02, 2026 | 33.30B |
| September 01, 2026 | 33.37B |
| August 31, 2026 | 34.63B |
| August 28, 2026 | 34.67B |
| Date | Value |
|---|---|
| August 27, 2026 | 34.01B |
| August 26, 2026 | 34.00B |
| August 25, 2026 | 34.13B |
| August 24, 2026 | 33.53B |
| August 21, 2026 | 33.39B |
| August 20, 2026 | 32.95B |
| August 19, 2026 | 33.27B |
| August 18, 2026 | 31.73B |
| August 17, 2026 | 31.79B |
| August 14, 2026 | 32.38B |
| August 13, 2026 | 32.70B |
| August 12, 2026 | 32.60B |
| August 11, 2026 | 32.43B |
| August 10, 2026 | 31.74B |
| August 07, 2026 | 30.57B |
| August 06, 2026 | 32.20B |
| August 05, 2026 | 32.31B |
| August 04, 2026 | 32.19B |
| August 03, 2026 | 31.04B |
| July 31, 2026 | 30.43B |
| July 30, 2026 | 30.08B |
| July 29, 2026 | 30.91B |
| July 28, 2026 | 30.14B |
| July 27, 2026 | 29.29B |
| July 24, 2026 | 28.17B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| IDEXX Laboratories, Inc. | 40.89B |
| Accuray, Inc. | 33.56M |
| Micron Solutions, Inc. | 0.1625M |
| Eli Lilly & Co. | 1.076T |
| Neogen Corp. | 2.645B |
Market Cap Related Metrics
| PE Ratio | 20.97 |
| PS Ratio | 5.652 |
| PEG Ratio | 2.15 |
| Price to Book Value | 4.794 |
| Price to Free Cash Flow | 19.62 |
| Price | 218.89 |
| Earnings Yield | 4.77% |
| PEGY Ratio | 1.928 |
| Operating PE Ratio | 16.62 |
| Normalized PE Ratio | 20.82 |